CorMedix Inc.
CRMD
$6.38
$0.010.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 312.10% | 810.22% | 4,829.51% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 312.10% | 810.22% | 4,829.51% | -- | -- |
| Cost of Revenue | 894.54% | 1,092.07% | 265.32% | 95.08% | -- |
| Gross Profit | 290.36% | 793.68% | 12,682.42% | 4,679.71% | -- |
| SG&A Expenses | 91.14% | 174.85% | 6.30% | -5.86% | 14.89% |
| Depreciation & Amortization | 19,361.80% | 6,891.33% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 224.46% | 259.00% | 25.37% | 13.48% | 16.62% |
| Operating Income | 435.90% | 1,661.95% | 227.73% | 220.48% | 182.56% |
| Income Before Tax | 319.23% | 1,993.41% | 243.80% | 230.16% | 191.26% |
| Income Tax Expenses | 21,213,250.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.13% | 4,009.64% | 240.11% | 242.71% | 191.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.13% | 4,009.64% | 240.11% | 242.71% | 191.26% |
| EBIT | 435.90% | 1,661.95% | 227.73% | 220.48% | 182.56% |
| EBITDA | 510.24% | 1,817.70% | 229.44% | 221.61% | 183.52% |
| EPS Basic | -24.49% | 3,129.24% | 218.85% | 225.76% | 185.14% |
| Normalized Basic EPS | 296.78% | 1,547.80% | 221.95% | 214.73% | 185.13% |
| EPS Diluted | -28.28% | 2,620.00% | 212.00% | 219.24% | 185.14% |
| Normalized Diluted EPS | 233.11% | 1,374.92% | 215.18% | 208.53% | 185.13% |
| Average Basic Shares Outstanding | 28.18% | 29.08% | 17.89% | 13.46% | 7.17% |
| Average Diluted Shares Outstanding | 52.69% | 46.56% | 24.81% | 19.95% | 7.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |